[1]
ShahT., LiddleR., BranchM., JowellP., ObandoJ., and PoleskiM., “Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial”, JOP, vol. 13, no. 5, pp. 514-518, Sep. 2012.